These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Uncoupling protein 2 deficiency mimics the effects of hypoxia and endoplasmic reticulum stress on mitochondria and triggers pseudohypoxic pulmonary vascular remodeling and pulmonary hypertension. Dromparis P; Paulin R; Sutendra G; Qi AC; Bonnet S; Michelakis ED Circ Res; 2013 Jul; 113(2):126-36. PubMed ID: 23652801 [TBL] [Abstract][Full Text] [Related]
12. Ischemia-induced Drp1 and Fis1-mediated mitochondrial fission and right ventricular dysfunction in pulmonary hypertension. Tian L; Neuber-Hess M; Mewburn J; Dasgupta A; Dunham-Snary K; Wu D; Chen KH; Hong Z; Sharp WW; Kutty S; Archer SL J Mol Med (Berl); 2017 Apr; 95(4):381-393. PubMed ID: 28265681 [TBL] [Abstract][Full Text] [Related]
13. Redox Biology of Peroxisome Proliferator-Activated Receptor-γ in Pulmonary Hypertension. Tseng V; Sutliff RL; Hart CM Antioxid Redox Signal; 2019 Oct; 31(12):874-897. PubMed ID: 30582337 [No Abstract] [Full Text] [Related]
14. Mitochondrial bioenergetics and pulmonary dysfunction: Current progress and future directions. Ten VS; Ratner V Paediatr Respir Rev; 2020 Apr; 34():37-45. PubMed ID: 31060947 [TBL] [Abstract][Full Text] [Related]
15. Oxidative and nitrosative signalling in pulmonary arterial hypertension - Implications for development of novel therapies. Hansen T; Galougahi KK; Celermajer D; Rasko N; Tang O; Bubb KJ; Figtree G Pharmacol Ther; 2016 Sep; 165():50-62. PubMed ID: 27216365 [TBL] [Abstract][Full Text] [Related]
16. Sex differences and altered mitophagy in experimental pulmonary hypertension. Bazan IS; Kim SJ; Ardito TA; Zhang Y; Shan P; Sauler M; Lee PJ Am J Physiol Lung Cell Mol Physiol; 2022 May; 322(5):L761-L769. PubMed ID: 35137625 [TBL] [Abstract][Full Text] [Related]
17. Mitochondrial hyperpolarization in pulmonary vascular remodeling. Mitochondrial uncoupling protein deficiency as disease model. Pak O; Sommer N; Hoeres T; Bakr A; Waisbrod S; Sydykov A; Haag D; Esfandiary A; Kojonazarov B; Veit F; Fuchs B; Weisel FC; Hecker M; Schermuly RT; Grimminger F; Ghofrani HA; Seeger W; Weissmann N Am J Respir Cell Mol Biol; 2013 Sep; 49(3):358-67. PubMed ID: 23590303 [TBL] [Abstract][Full Text] [Related]
18. Increased in vivo mitochondrial oxygenation with right ventricular failure induced by pulmonary arterial hypertension: mitochondrial inhibition as driver of cardiac failure? Balestra GM; Mik EG; Eerbeek O; Specht PA; van der Laarse WJ; Zuurbier CJ Respir Res; 2015 Feb; 16(1):6. PubMed ID: 25645252 [TBL] [Abstract][Full Text] [Related]
19. Targeting mitochondrial reactive oxygen species to modulate hypoxia-induced pulmonary hypertension. Adesina SE; Kang BY; Bijli KM; Ma J; Cheng J; Murphy TC; Michael Hart C; Sutliff RL Free Radic Biol Med; 2015 Oct; 87():36-47. PubMed ID: 26073127 [TBL] [Abstract][Full Text] [Related]
20. Targeting Mitochondrial Metabolic Dysfunction in Pulmonary Hypertension: Toward New Therapeutic Approaches? Riou M; Enache I; Sauer F; Charles AL; Geny B Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298522 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]